FDA Orange Book · active-ingredient family
Sulfur hexafluoride lipid-type a microspheres
Sulfur hexafluoride lipid-type a microspheres is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:LUMASON · NDA 203684
1
Brand (NDA)
0
Generics (ANDA)
3
Listed patents
0
Exclusivity periods
Brand (NDA) products · for suspension
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| LUMASONRLD | BRACCO | NDA 203684 | — | Oct 15, 2014 |
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10232061 | Jul 06, 2038 | in 12 yr 3 mo | Product |
| 10335502 | Jul 06, 2038 | in 12 yr 3 mo | Product |
| 11723869 | May 15, 2039 | in 13 yr 1 mo | ProductU-3666 |
Sulfur hexafluoride lipid-type a microspheres — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

